Alzheimer’s disrupts a lot of the brain, but it doesn’t disrupt your ability to feel emotion. You can still feel loved, lonely, sad or upset.
“No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden,” Maria Shriver and George Vradenburg wrote…
Getting an accurate Alzheimer’s diagnosis can take years — and several visits to the doctor. After taking a medical history, neurological exam, and blood tests…
Treatment with a powerful magnet is one of the newest experimental therapies being used to try to turn back the clock on Alzheimer’s disease….
For 25 years, Mark Sennet worked as a photojournalist and celebrity photographer for Life and People Magazine. He has photographed royals, presidents, sports legends,…
More than one in ten people who catch COVID don’t fully recover — developing a chronic condition called long COVID which causes a variety…
Members of the Being Patient community are increasingly curious to learn their genetic status as it relates to Alzheimer’s risk. A story I was…
When Reda Harrison came back from vacation to her University of Kentucky hospital plastic surgery coordinator job at home in Lexington, Kentucky, something was…
The genetic risk of developing Alzheimer’s disease is more strongly influenced by the mother’s side than the father’s side, a recent study has discovered….
According to new diagnostic criteria for Alzheimer’s, a blood test might be all you need to get diagnosed in the near future. At this…
On July 25th, European regulators said no to Eisai and Biogen’s anti-amyloid drug Leqembi for early stage Alzheimer’s. The European Medicines Agency (Europe’s version…
After actor Lauren Miller Rogen’s mother was diagnosed with Alzheimer’s, she and her husband, actor Seth Rogen, decided to apply their powers of entertainment…
In a recent survey, Being Patient put a question to readers: “What is the biggest barrier preventing you from seeking a trial?” The most…
Cassava Sciences’ experimental Alzheimer’s drug simufilam is currently in clinical trials. Meanwhile, the company is experiencing a major shake-up. Its CEO and lead neuroscientist…
It’s been a big year for Alzheimer’s research. Between July 6 of last year and this July 2, two disease-modifying drugs for Alzheimer’s disease received full…